Nepedia
Back to Discover
Advanced Reader
🧬

Katalin Karikó

life science Maturity 5-7 religion war conflict Next article →

This article covers sensitive topics: religion, war_conflict. Parents can manage visibility in Parental Controls.

Katalin Karikó is a Hungarian and American biochemist whose research changed the field of medicine. She specializes in ribonucleic acid (RNA)-mediated mechanisms. Specifically, she focuses on in vitro-transcribed messenger RNA (mRNA). mRNA acts as a set of instructions for cells to build proteins. Karikó’s work laid the essential groundwork for using mRNA in protein replacement therapy. This research eventually allowed for the development of highly effective vaccines. Her persistence in a difficult scientific field led to a global medical breakthrough.

For many years, using synthetic mRNA in the human body was nearly impossible. When scientists injected mRNA, it triggered a strong inflammatory response. The body's immune system recognized the mRNA as a foreign threat and attacked it. Karikó discovered a way to solve this by studying transfer RNA (tRNA). She noticed that tRNA did not provoke the same immune reaction as mRNA. By comparing the two, she and her collaborator, Drew Weissman, found a chemical solution. They discovered that replacing the nucleoside uridine with pseudouridine could suppress the immune response. This modification made the mRNA non-immunogenic, meaning it would not trigger an unwanted attack from the body.

Drew Weissman and Katalin Karikó Life Science Medalists
Drew Weissman and Katalin Karikó Life Science Medalists

To make this technology work as a medicine, the mRNA must reach the right part of the body. Because mRNA is a very fragile molecule, it needs protection. Karikó worked on a delivery technique using lipid nanoparticles. These are tiny droplets made of fat that encapsulate the mRNA. The mixing process creates a dense particle that acts like a protective bubble. These nanoparticles shield the mRNA until it can reach its target area inside the cells. This delivery system was proven effective in animal studies and became a core part of modern vaccine technology.

Karikó's path to these discoveries was filled with significant professional obstacles. She earned her BSc in biology in 1978 and her PhD in biochemistry in 1982 from the University of Szeged. In 1985, she moved from Hungary to the United States to seek research opportunities. Her journey included working at Temple University and Johns Hopkins University. At the University of Pennsylvania, she faced intense skepticism regarding mRNA. Many researchers and companies doubted the potential of mRNA-based therapy. Because she struggled to secure grants, the university demoted her in 1995 and denied her tenure. Despite these setbacks, she refused to abandon her research.

In 1997, Karikó met immunologist Drew Weissman at the University of Pennsylvania. Their collaboration combined biochemistry with immunology to solve the problems of mRNA stability and immune response. Together, they developed the nucleoside modifications that are now protected by United States patents. Their work was eventually licensed by companies like BioNTech and Moderna. This technology was used to create the BioNTech/Pfizer and Moderna vaccines. These two vaccines were the most effective tools used to fight the SARS-CoV-2 virus. They contributed significantly to containing the COVID-19 pandemic worldwide.

Because of her life's work, Karikó has received many of the world's highest honors. In 2023, she and Drew Weissman were awarded the Nobel Prize in Physiology or Medicine. She has also received the Lasker–DeBakey Clinical Medical Research Award. In 2022, she won the Tang Prize Award in Biopharmaceutical Science. Time Magazine named her one of the Heroes of the Year in 2021. These awards recognize the massive impact her research has had on global health.

Karikó Katalin falfestmény Budapesten a Krisztina körúton 2021
Karikó Katalin falfestmény Budapesten a Krisztina körúton 2021

Today, Karikó's influence extends far beyond the COVID-19 pandemic. Her research into mRNA-mediated mechanisms is opening doors to a new class of drugs. This includes potential uses in generating pluripotent stem cells and advancing mRNA-based gene therapy. She has held leadership roles, including serving as a senior vice president at BioNTech RNA Pharmaceuticals. She also returned to her roots as a professor at the University of Szeged in Hungary. Her career demonstrates how dedicated research can eventually transform the entire landscape of human medicine.

648 words

Where will your curiosity go next?

Keep exploring at your chosen reading level.

🖼️ Images & Media (4)
File:Karikó Katalin with Statue of Albert Szent-Györgyi.jpg
Karikó Katalin with Statue of Albert...
File:Drew Weissman and Katalin Karikó Life Science Medalists.jpg
Drew Weissman and Katalin Karikó Life...
File:Karikó Katalin falfestmény Budapesten a Krisztina körúton 2021.jpg
Karikó Katalin falfestmény Budapesten a...
File:Susan Francia Rower.jpg
Susan Francia Rower.jpg
More to explore

What is Nepedia?

A free, ad-free encyclopedia for children. Every article is written at five reading levels, so the same page works for a five-year-old and a fifteen-year-old — use the level switcher above to see this one change. No account needed to read.